The Federal Service for the Oversight of Consumer Protection and Welfare in Russia has recently taken on a hands-on approach toward the urgent need of addressing the problem against antibiotic-resistant bacteria with bacteriophages.
News
Proteon Pharmaceuticals receives funding from Nutreco, Aqua-Spark & PFR Life Science for commercializing bacteriophage-based products for livestock and aquaculture.
Researchers created a new genus of bacteriophages; Colneyvirus after the discovery of a phage against Clostridium difficile.
Researchers have seen a strong antibody production from an inhalable phage-based COVID-19 vaccine.
EU and FAO award Biochimpharm with grant for the production of a new product for veterinary use, PowerPhage.
- News
TechnoPhage announces FDA Fast Track Designation granted to TP-102 for the treatment of patients with infected diabetic foot ulcers
TechnoPhage announces FDA Fast Track Designation granted to TP-102 for the treatment of patients with infected diabetic foot ulcers.
- News
Phico Therapeutics raises £7 million investment to support SASPject novel engineered phage technology
Phico Therapeutics raises £7 million investment to support SASPject advancement, novel engineered phage technology for next-generation antibiotics to curb antimicrobial resistance (AMR).
The National Institute of Allergy and Infectious Diseases (NIAID), has awarded 12 institutes with grants towards phage therapy research.
Phico Therapeutics receives funding from CARB-X towards the development of engineered bacteriophage with SASP gene targeting Pseudomonas aeruginosa.
BiomX updates on pipeline products against Cystic fibrosis (CF), Atopic dermatitis (AD), Inflammatory bowel disease (IBD), and Primary sclerosing cholangitis (PSC), as well as a treatment against Acne-prone skin and Colorectal cancer.
Newer Posts